Skip to main content
. 2015 Oct 17;6(39):42300–42311. doi: 10.18632/oncotarget.5982

Figure 1. High c-MYC and low MYCBP2 expression and correlation with clinical features in ALL patients.

Figure 1

A. Comparison of c-MYC expression in B-ALL and T-ALL with normal BM control; B. Comparison of MYCBP2 expression in B-ALL and T-ALL with normal BM control; C. Correlation of high c-MYC expression with high risk factors (high WBC, CD13+ cells, and low CR rate); D–E. Correlation of high c-MYC expression with proliferation indicators.